Quick Answer
NANOVIRICIDES, INC. reported Research And Development Expense of $5.55 million for the year ending 2025.
- NANOVIRICIDES, INC. showed an increase of +2.1% in Research And Development Expense from 2024 to 2025.
- This data is from NANOVIRICIDES, INC.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), NANOVIRICIDES, INC.'s Research And Development Expense has grown by 29.3%.
- Historical annual values: Fiscal year 2025: $5.55 million | Fiscal year 2024: $5.44 million | Fiscal year 2023: $6.39 million | Fiscal year 2022: $5.78 million | Fiscal year 2021: $6.11 million | Fiscal year 2020: $4.70 million | Fiscal year 2019: $5.92 million | Fiscal year 2018: $5.91 million | Fiscal year 2017: $6.57 million | Fiscal year 2016: $5.03 million | Fiscal year 2015: $3.66 million | Fiscal year 2014: $5.13 million | Fiscal year 2013: $4.29 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: